Topical 0.4% Ketorolac and Vitreoretinal Surgery

Emory University

Status and phase: Completed; Phase 3; Phase 2

Conditions: Surgery

Treatments: Drug: Ketorolac

Study type: Interventional

Funder types: Other

Identifiers

NCT00576329

IRB00000517

Details and patient eligibility

About

To determine whether use of topical 0.4% ketorolac has any effect on pupil size during vitreoretinal surgery.

Full description

Other outcomes will be to assess postoperative pain and inflammation and visual acuity.

Enrollment: 76 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age of 18, routine elective vitrectomy

Exclusion criteria

• history of trauma, uveitis, prior intraocular surgery within 3 months, requirement of mechanical pupil dilation, prior inclusion of other eye

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind

---

76 participants in 2 patient groups, including a placebo group

A

Placebo Comparator group

Treatment:

Drug: Ketorolac

B

Experimental group

Treatment:

Drug: Ketorolac